90
Participants
Start Date
May 31, 2001
Primary Completion Date
April 30, 2006
alvocidib
Given IV
leucovorin calcium
fluorouracil
irinotecan hydrochloride
Mayo Clinic, Rochester
National Cancer Institute (NCI)
NIH